mesoridazine
Sign in to saveAlso known as NC-123, TPS-23, thioridazine thiomethyl sulfoxide, thioridazine-2-sulfoxide, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylsulfinyl)phenothiazine, 2-methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfinyl phenothiazine
Mesoridazine (Serentil) is a phenothiazine class drug that is used in the treatment of schizophrenia. It is one of the active metabolites of thioridazine. The drug's name is derived from the methylsulfoxy and piperidine functional groups in its chemical structure.
Research
224 papers- Mesoridazine.2006
- Mesoridazine -- a pharmacodynamic and pharmacokinetic profile.The Journal of clinical psychiatry · 1981
- Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel.Journal of molecular and cellular cardiology · 2004
- Mesoridazine and human sleep.British journal of clinical pharmacology · 1976
- Mesoridazine (Serentil).The Medical letter on drugs and therapeutics · 1971
via PubMed
~2 min read
Encyclopedic overview
2 sectionsContents
- Synthesis
- References
Mesoridazine (Serentil) is a phenothiazine class drug that is used in the treatment of schizophrenia. It is one of the active metabolites of thioridazine. The drug's name is derived from the methylsulfoxy and piperidine functional groups in its chemical structure.
It has central antiadrenergic, antidopaminergic, antiserotonergic and weak muscarinic anticholinergic effects.
Excerpted from Wikipedia’s “mesoridazine” article, available under the CC BY-SA 4.0 licence.